Navigation Links
Pharmaceutical Institute Launches New E-Course Focused on Health Policy
Date:6/17/2009

RALEIGH, N.C., June 17 /PRNewswire/ -- Pharmaceutical Institute (PI), a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the release of a new e-course titled, Introduction to Health Policy. The course is the newest addition to the company's Managed Markets Excellence(TM) series. The new Introduction to Health Policy e-course provides a comprehensive overview of the challenges confronting the US healthcare system.

"As politicians and policy makers continue to debate options to reform our healthcare system, pharmaceutical and biotech companies are working to understand the potential effects of policy changes, both large and small," says Garry O'Grady, Senior Vice President of the Pharmaceutical Institute. "It is important for pharmaceutical and biotech companies to keep their teams abreast of these potential policy changes and to understand the possible implications to their business."

The Introduction to Health Policy e-course, developed in partnership with subject-matter experts from Campbell Alliance, provides team members with the background necessary to understand the potential policy changes facing the industry, as well as the impacts of these changes on the way companies develop, market, and sell their products. The 2-hour e-course consists of four comprehensive modules, providing team members with a solid foundation on current health policy issues, including

  • Health Policy Stakeholders -- This module provides an introduction to key players in the development of health policy, their roles, and the differing perspectives they "bring to the table." Team members will also become familiar with leaders spearheading current efforts to achieve health insurance reform.
  • US Health Coverage - A Current View -- As a necessary backdrop for understanding healthcare reform
    '/>"/>

SOURCE Pharmaceutical Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , CALGARY, Dec. 2 /PRNewswire-F...or the "Company") (TSX:ONC; NASDAQ: ONCY ) announc...nounced unit offering, the underwriters have exerc...ased an additional 637,500 units. Each unit is com...re purchase warrant, and was sold at a price of US...
(Date:12/2/2009)... , , SINGAPORE, Dec. 2 /PRNewswire/...ns on its novel oral JAK2 inhibitor, SB1518, at Th...ng and Exposition in New Orleans. ,, Data will ...e 1 dose-escalation trial of SB1518 detailing its ...ynamic (PK/PD) profile in dose levels ranging from...
(Date:12/2/2009)... , The Scientist, a leadi... ranked Photometrics’ Evolve “Intellig...on’s “Top 10 Innovations of 2009. , ... The Evolve ™ EMCCD camera from Photometr...formance CCD and EMCCD cameras for the life scienc...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,..., http://www.reportlinker.com/p0164431/Industria...ustrial Enzymes market is an oligopoly with few st... in niche market activities. Keen competition and ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...., May 2 Osteotech, Inc.,(Nasdaq: OSTE ), a lead...,regenerative healing, announced today that its Pl...Reconstruction Program led by Dr. Jeffrey Hollinge...ch was prepared under the,auspices of the New Jers...,Rutgers University, is part of a multi-institutio...
...M) Technology Raising the Bar in Motion Preservati...hnology,Inc., a leader in innovative medical devic...ion of its next generation cervical total disc,rep.... The surgeries were,performed by Drs. Hansen Yuan...ients with degenerative disc disease (DDD) otherwi...
...l/Webcast to be Held Wednesday, May 7, 2008 at 10:...echnologies, Inc. (Nasdaq: EMIS ) will host a con...the first quarter ended March 31, 2008 on,Wednesda...f the conference call can be accessed through the,...The live conference call dial-in,number is: 1-800-...
Other Biology Technology:Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine 2Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine 3Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device 2Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results 2
(Date:12/3/2009)...ntents of this message: , , Preliminary Press...to California Academy of Sciences museum, Attent... NCSWA holiday dinner registration deadline 10 D... News Media Registration Form pre-registration dea..., For important information regarding visas for ...
(Date:12/3/2009)...and Rapids, Mich. (Dec. 3, 2009) Van Andel Rese...precisely how the plant hormone abscisic acid (ABA...ond to environmental stresses such as drought and ...ature , could help engineer crops that thrive in h...al food shortages. The findings could also have i...
(Date:12/3/2009)...rest dwellers must be included in the design of th...void a humanitarian crisis, according to a scienti...in Nature , Dr Simon Lewis argues that at least 5...openhagen, known as REDD (Reducing Emissions from ...forest dwellers directly, and their property right...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Bridges To Recovery a one of a Kind Los Angeles Facility Providing In Patient Psychiatric Treatment Acquires License To Provide Additional Beds 58731 1Bridges To Recovery a one of a Kind Los Angeles Facility Providing In Patient Psychiatric Treatment Acquires License To Provide Additional Beds 58731 2Intercept Pharmaceuticals FXR Agonist INT 747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty 5182 1Intercept Pharmaceuticals FXR Agonist INT 747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty 5182 2Energy autonomous sensors for aircraft 14324 1Energy autonomous sensors for aircraft 14324 2
...er Current , M. Belkin, A. Snezhko, I.S. Aranson, ...ng) , Physicists at Argonne National Laboratory h...er and subjected to an alternating magnetic field ... the flow of the surrounding fluid. Current incarn... long, but the team envisions much smaller version...
...ssful academic entrepreneurs has teamed up with th... and development in membrane biology to pharmaceut...ny Marchington, who turned his spin-out company Ox...rk alongside the Universitys new Centre for Integr...ontracts with industry, based on Leeds world-class...
...EASE , Spinning a new role for CDs and CD player...he hardware used to play these popular audio and v...s a new generation of portable, inexpensive instru...ased testing, scientists in Spain are reporting in...semi-monthly journal. CD technology could be adap...
Other Biology News:Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 2Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 3New partnership offers outsourced R&D in membrane biology 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 3American Chemical Society's Weekly PressPac -- Sept. 19, 2007 4American Chemical Society's Weekly PressPac -- Sept. 19, 2007 5American Chemical Society's Weekly PressPac -- Sept. 19, 2007 6American Chemical Society's Weekly PressPac -- Sept. 19, 2007 7American Chemical Society's Weekly PressPac -- Sept. 19, 2007 8
Normal Porcine Serum from Equitech-Bio
3-O-Methylguanosine 5-Triphosphate, Sodium from GE Healthcare, formerly Amersham Biosciences
Porcine Serum from Innovative Research
Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively from BioChain
Biology Products: